WALTHAM, Mass., Nov. 19 /PRNewswire/ --Graeme GreenPh.D, analyst at Decision Resources, is available to discuss the results of the JUPITER study presented at the American Heart Association (AHA) Scientific Sessions this month.
The results of the 17,802-patient trial demonstrated AstraZeneca's Crestor to be effective at cutting the risk of heart attack and death among patients who seemed healthy but showed high levels of high-sensitivity C-reactive protein (hsCRP). In the study, those who had normal LDL cholesterol levels, but who were identified as being at increased cardiovascular risk due to elevated hsCRP, received either Crestor or placebo. Findings showed that those who took Crestor had a 44 percent reduction in the occurrence of a first major cardiovascular event and a 47 percent reduction in the combined risk of stroke, heart attack or cardiovascular death, compared with those who took placebo. The data also indicated that total mortality in the Crestor group was reduced by 20 percent versus the placebo group.
Dr. Green is available to discuss:
To speak with Dr. Green, please contact Heather Hilty at 781-296-2536 or firstname.lastname@example.org.
About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
Heather Hilty Elizabeth Marshall Decision Resources Decision Resources, Inc. 781-296-2536 781-296-2563 email@example.com firstname.lastname@example.org
|SOURCE Decision Resources|
Copyright©2008 PR Newswire.
All rights reserved